| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Aldeyra Therapeutics, Inc. (ALDX) has 8 insiders with recent SEC Form 4 filings, including 7 buys and 8 sells. ALDX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 221.8K | $378.2K | - | |
| Dir | 62.7K | $107.0K | - | |
| Dir | 62.7K | $107.0K | - | |
| Dir | 62.7K | $107.0K | - | |
| Dir | 62.7K | $107.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 18, 2026 | Alfieri Michael | Principal Financial Officer | Buy | 5,000 | $1.42 | $7,100.00 | +200.0% | - | - | |
| Aug 13, 2025 | Alfieri Michael | Principal Financial Officer | Buy | 2,500 | $5.30 | $13,250.00 | New | -2.6% | - | |
| Aug 11, 2025 | MacHatha Stephen | Chief Development Officer | Sell | 22,073 | $5.15 | $113,713.47 | -9.1% | -2.3% | - | |
| Apr 3, 2025 | Perceptive Advisors LLC51 | 10% Owner | Sell | 3,400,000 | $1.42 | $4,828,000.00 | -36.7% | +181.7% | +16.9% | |
| Aug 12, 2024 | Greenberg Bruce | See Remarks | Sell | 10,834 | $4.74 | $51,313.07 | -7.9% | +15.6% | +12.8% | |
| Aug 12, 2024 | MacHatha Stephen | Chief Development Officer | Sell | 16,041 | $4.74 | $75,974.99 | -6.3% | +15.6% | +12.8% | |
| Apr 5, 2024 | Perceptive Advisors LLC51 | 10% Owner | Buy | 177,993 | $4.68 | $833,867.15 | +1.0% | -32.4% | -60.0% | |
| Apr 3, 2024 | Perceptive Advisors LLC51 | 10% Owner | Buy | 504,272 | $3.84 | $1,934,505.17 | +1.9% | -21.7% | -65.8% | |
| Mar 12, 2024 | MacHatha Stephen | Chief Development Officer | Sell | 29,768 | $3.31 | $98,605.15 | -5.6% | +28.8% | +132.3% | |
| Mar 12, 2024 | Brady Todd C | President And CEO | Sell | 183,238 | $3.17 | $580,759.68 | -5.7% | +28.8% | +132.3% |